Literature DB >> 21552039

Use of Ga-68 DOTATATE PET/CT to confirm portal vein tumor thrombosis in a patient with pancreatic neuroendocrine tumor.

Tze Chwan Lim1, Eik Hock Tan, Sumbul Zaheer.   

Abstract

A 37-year-old man complained of increasing severity and frequency of abdominal pain over a 2-year period. Initial contrast-enhanced computed tomography of the abdomen demonstrated diffuse enlargement of the pancreas associated with a filling defect in the portal vein, splenomegaly with wedge-shaped peripheral splenic hypodensities and multiple hepatic hypodensities. Findings were suggestive of a pancreatic malignancy complicated by hepatic metastases, splenic infarcts, and portal vein thrombosis. We describe the use of gallium-68 DOTA-DPhe1, Tyr3-octreotate positron emission tomography/computed tomography (Ga-68 DOTATATE PET/CT) in confirming the diagnosis of a pancreatic neuroendocrine tumor with portal vein tumor thrombosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21552039     DOI: 10.1097/RLU.0b013e318217398b

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

Review 1.  The role of molecular imaging in diagnosis of deep vein thrombosis.

Authors:  Sina Houshmand; Ali Salavati; Søren Hess; Mudalsha Ravina; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

Review 2.  Prospective of ⁶⁸Ga-radiopharmaceutical development.

Authors:  Irina Velikyan
Journal:  Theranostics       Date:  2013-12-10       Impact factor: 11.556

3.  Case Report: Pancreatic Neuroendocrine Tumor With Liver Metastasis and Portal Vein Thrombosis.

Authors:  Yulong Tian; Xingshun Qi; Afaf Aljbri; Ke Xu; Hongshan Zhong
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

4.  Vascular thrombosis as a cause of abdominal pain in a patient with neuroendocrine carcinoma of pancreas: Findings on (68)Ga-DOTANOC PET/CT.

Authors:  Niraj Naswa; Rakesh Kumar; Chandrasekhar Bal; Arun Malhotra
Journal:  Indian J Nucl Med       Date:  2012-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.